Search research articles
Contact Us
Filters
Showing results (141-150 of 194) with videos related to
Page
of 20
Sort By:
Blood Advances
|
November 2, 2022
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity
Timon A Bloedjes, Guus de Wilde, Gerarda H Khan, et al.
The Journal of Clinical Investigation
|
October 26, 2023
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions
Fumou Sun, Yan Cheng, Jin-Ran Chen, et al.
British Journal of Haematology
|
May 8, 2013
TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity
Moshe E Gatt, Kohichi Takada, Mala Mani, et al.
Blood
|
May 22, 2008
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities
Bart Barlogie, Mauricio Pineda-Roman, Frits van Rhee, et al.
Blood Cancer Journal
|
March 5, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing
Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng, et al.
Research Square
|
May 20, 2024
Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx
Dongzheng Gai, Perry C Caviness, Oxana P Lazarenko, et al.
Cancers
|
March 13, 2025
Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption
Dongzheng Gai, Perry C Caviness, Oxana P Lazarenko, et al.
British Journal of Haematology
|
October 28, 2008
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
Jumei Shi, Guido Tricot, Susann Szmania, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2012
Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1
Christoph J Heuck, Jackie Szymonifka, Emily Hansen, et al.
Nature Genetics
|
February 1, 1996
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia
T Nakamura, D A Largaespada, M P Lee, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 194) with videos related to
Sort By:
Page
of 20
Blood Advances
|
November 2, 2022
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity
Timon A Bloedjes, Guus de Wilde, Gerarda H Khan, et al.
The Journal of Clinical Investigation
|
October 26, 2023
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions
Fumou Sun, Yan Cheng, Jin-Ran Chen, et al.
British Journal of Haematology
|
May 8, 2013
TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity
Moshe E Gatt, Kohichi Takada, Mala Mani, et al.
Blood
|
May 22, 2008
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities
Bart Barlogie, Mauricio Pineda-Roman, Frits van Rhee, et al.
Blood Cancer Journal
|
March 5, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing
Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng, et al.
Research Square
|
May 20, 2024
Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx
Dongzheng Gai, Perry C Caviness, Oxana P Lazarenko, et al.
Cancers
|
March 13, 2025
Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption
Dongzheng Gai, Perry C Caviness, Oxana P Lazarenko, et al.
British Journal of Haematology
|
October 28, 2008
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
Jumei Shi, Guido Tricot, Susann Szmania, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2012
Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1
Christoph J Heuck, Jackie Szymonifka, Emily Hansen, et al.
Nature Genetics
|
February 1, 1996
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia
T Nakamura, D A Largaespada, M P Lee, et al.
Page
of 20